30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

enGene Holdings Inc (ENGN)

Track

The most recent insider trading activity occurred on October 30, 2024. A significant buy transaction of approximately $5 million was executed by Forbion Growth Opportunities Fund I Cooperatief U.A. This follows a series of other buy transactions by the same entity throughout October and September. Earlier in the year, there were sell transactions by FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC and a buy transaction by an executive.
Stock chart
Ticker: ENGN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Forbion Growth Opportunities Fund I Cooperatief U.A.
1 purchase — total 4,999,993 USD
Buy 30 Oct 2024
Value US$2,073,235.48 | Price 431.34 | Shares 61,999
Buy 8 Oct 2024
Value US$3,667,374.09 | Price 486.68 | Shares 42,467
Buy 7 Oct 2024
Value US$77,530.82 | Price 6.55 | Shares 11,844
Buy 4 Oct 2024
Value US$39,241.97 | Price 6.54 | Shares 5,997
Buy 3 Oct 2024
Value US$37,396.97 | Price 6.48 | Shares 5,769
Buy 2 Oct 2024
Value US$64,696.95 | Price 6.37 | Shares 10,153
Buy 1 Oct 2024
Value US$227,157.95 | Price 6.44 | Shares 35,279
Buy 30 Sep 2024
Value US$2,163,362.22 | Price 6.34 | Shares 341,332
Buy 27 Sep 2024
Value US$20,688.39 | Price 6.38 | Shares 3,243
Buy 27 Sep 2024
Value US$228,010.81 | Price 5.94 | Shares 38,396
Buy 27 Sep 2024
Value US$57,000.00 | Price 5.70 | Shares 10,000
Sale 22 Apr 2024
Value US$717,810.00 | Price 15.00 | Shares 47,854
Sale 19 Apr 2024
Value US$1,500.00 | Price 15.00 | Shares 100
Sale 18 Apr 2024
Value US$68,670.75 | Price 15.01 | Shares 4,575
Buy 18 Mar 2024
Value US$47,116.60 | Price 0.89 | Shares 52,940
Buy 29 Dec 2023
Value US$87,450.61 | Price 9.09 | Shares 9,620
Buy 29 Dec 2023
Value US$3,320.00 | Price 8.30 | Shares 400
Buy 28 Dec 2023
Value US$38,826.92 | Price 7.69 | Shares 5,050
Buy 27 Dec 2023
Value US$19,711.45 | Price 7.17 | Shares 2,750
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-01 2024-10-30 B Purchase
2.6
Forbion Growth Opportunities Fund I Cooperatief U.A.
Large shareholder
61,999 +19.9%
431.34
US$2,073,235 		61,999 +19.9% 431.34 US$2,073,235
2024-10-18 2024-10-08 B Purchase
2.6
Forbion Growth Opportunities Fund I Cooperatief U.A.
Large shareholder
42,467 -28.8%
486.68
US$3,667,374 		42,467 -28.8% 486.68 US$3,667,374
2024-10-18 2024-10-07 B Purchase
2.6
Forbion Growth Opportunities Fund I Cooperatief U.A.
Large shareholder
67,126 -26.4%
40.12
US$516,534 		67,126 -26.4% 40.12 US$516,534
2024-10-18 2024-10-04 B Purchase
2.6
Forbion Growth Opportunities Fund I Cooperatief U.A.
Large shareholder
5,997 +0.2%
6.54
US$39,242 		5,997 +0.2% 6.54 US$39,242
2024-10-18 2024-10-03 B Purchase
2.6
Forbion Growth Opportunities Fund I Cooperatief U.A.
Large shareholder
5,769 +0.2%
6.48
US$37,397 		5,769 +0.2% 6.48 US$37,397
2024-10-18 2024-10-02 B Purchase
2.6
Forbion Growth Opportunities Fund I Cooperatief U.A.
Large shareholder
10,153 +0.4%
6.37
US$64,697 		10,153 +0.4% 6.37 US$64,697
2024-10-18 2024-10-01 B Purchase
2.6
Forbion Growth Opportunities Fund I Cooperatief U.A.
Large shareholder
35,279 +1.5%
6.44
US$227,158 		35,279 +1.5% 6.44 US$227,158
2024-10-18 2024-09-30 B Purchase
2.6
Forbion Growth Opportunities Fund I Cooperatief U.A.
Large shareholder
341,332 +16.6%
6.34
US$2,163,362 		341,332 +16.6% 6.34 US$2,163,362
2024-10-18 2024-09-27 B Purchase
2.6
Forbion Growth Opportunities Fund I Cooperatief U.A.
Large shareholder
3,243 +0.2%
6.38
US$20,688 		3,243 +0.2% 6.38 US$20,688
2024-10-18 2024-09-27 B Purchase
2.6
Forbion Growth Opportunities Fund I Cooperatief U.A.
Large shareholder
38,396 +1.9%
5.94
US$228,011 		38,396 +1.9% 5.94 US$228,011
2024-10-01 2024-09-27 B Purchase
3.1
Cooper Ronald Harold Wilfred

Chief Executive Officer

Executive Director
10,000 +inf%
5.70
US$57,000 		10,000 +inf% 5.70 US$57,000
2024-04-22 2024-04-22 S Sale
3.8
FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC
Large shareholder
47,854 -1.6%
15.00
US$717,810 		47,854 -1.6% 15.00 US$717,810
2024-04-22 2024-04-19 S Sale
3.8
FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC
Large shareholder
100 -0.0%
15.00
US$1,500 		100 -0.0% 15.00 US$1,500
2024-04-22 2024-04-18 S Sale
3.8
FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC
Large shareholder
4,575 -0.1%
15.01
US$68,671 		4,575 -0.1% 15.01 US$68,671
2024-03-20 2024-03-18 B Purchase
Cheung, Anthony

Senior Officer of Issuer

Officer
52,940 +106.0%
0.89
US$47,117 		52,940 +106.0% 0.89 US$47,117
2024-10-18 2023-12-29 B Purchase
2.6
Forbion Growth Opportunities Fund I Cooperatief U.A.
Large shareholder
9,620 +0.5%
9.09
US$87,451 		9,620 +0.5% 9.09 US$87,451
2024-10-18 2023-12-29 B Purchase
2.6
Forbion Growth Opportunities Fund I Cooperatief U.A.
Large shareholder
400 +0.0%
8.30
US$3,320 		400 +0.0% 8.30 US$3,320
2024-10-18 2023-12-28 B Purchase
2.6
Forbion Growth Opportunities Fund I Cooperatief U.A.
Large shareholder
5,050 +0.3%
7.69
US$38,827 		5,050 +0.3% 7.69 US$38,827
2024-10-18 2023-12-27 B Purchase
2.6
Forbion Growth Opportunities Fund I Cooperatief U.A.
Large shareholder
2,750 +0.1%
7.17
US$19,711 		2,750 +0.1% 7.17 US$19,711
Explore more

More insider trading research around enGene Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America